3//SEC Filing
Flagship Pioneering Fund VII, L.P. 3
Accession 0000899243-22-025722
CIK 0001609809other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:00 PM ET
Size
7.1 KB
Accession
0000899243-22-025722
Insider Transaction Report
Form 3
Holdings
- 5,825,495(indirect: By Flagship Pioneering Fund VII, L.P.)
Common Stock
Footnotes (2)
- [F1]On July 5, 2022, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 5,825,495 shares of the Issuer's Common Stock in a registered direct offering at a price of $3.15 per share.
- [F2]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Dr. Afeyan is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001805916
Filing Metadata
- Form type
- 3
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:00 PM ET
- Size
- 7.1 KB